Search details
1.
Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1-associated optic pathway gliomas in children.
Pediatr Blood Cancer
; 68(4): e28833, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33336845
2.
A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma.
Pediatr Blood Cancer
; 68(2): e28787, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33140540
3.
Effect of lapatinib on meningioma growth in adults with neurofibromatosis type 2.
J Neurooncol
; 139(3): 749-755, 2018 Sep.
Article
in English
| MEDLINE | ID: mdl-29948766
4.
Pre-irradiation intensive induction and marrow-ablative consolidation chemotherapy in young children with newly diagnosed high-grade brainstem gliomas: report of the "head-start" I and II clinical trials.
J Neurooncol
; 140(3): 717-725, 2018 Dec.
Article
in English
| MEDLINE | ID: mdl-30392092
5.
Utility of MRI versus tumor markers for post-treatment surveillance of marker-positive CNS germ cell tumors.
J Neurooncol
; 129(3): 541-544, 2016 09.
Article
in English
| MEDLINE | ID: mdl-27406584
6.
Cross-species genomics matches driver mutations and cell compartments to model ependymoma.
Nature
; 466(7306): 632-6, 2010 Jul 29.
Article
in English
| MEDLINE | ID: mdl-20639864
7.
Noncarboplatin-induced Sensorineural Hearing Loss in a Patient With an Intracranial Nongerminomatous Germ Cell Tumor.
J Pediatr Hematol Oncol
; 38(4): 312-6, 2016 05.
Article
in English
| MEDLINE | ID: mdl-23652864
8.
Multimodality therapy for CNS mixed malignant germ cell tumors (MMGCT): results of a phase II multi-institutional study.
J Neurooncol
; 118(1): 93-100, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24700239
9.
Long-term survival of children less than six years of age enrolled on the CCG-945 phase III trial for newly-diagnosed high-grade glioma: a report from the Children's Oncology Group.
Pediatr Blood Cancer
; 61(1): 151-7, 2014 Jan.
Article
in English
| MEDLINE | ID: mdl-24038913
10.
Genome-wide analysis of DNA copy number alterations and loss of heterozygosity in intracranial germ cell tumors.
Pediatr Blood Cancer
; 61(4): 593-600, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-24249158
11.
A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer.
Pediatr Blood Cancer
; 61(4): 636-42, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-24123865
12.
Final report of the phase II NEXT/CNS-GCT-4 trial: GemPOx followed by marrow-ablative chemotherapy for recurrent intracranial germ cell tumors.
Neurooncol Pract
; 11(2): 188-198, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38496907
13.
Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain Tumors.
Mol Cancer Res
; 22(1): 21-28, 2024 Jan 02.
Article
in English
| MEDLINE | ID: mdl-37870438
14.
Potential role of ventricular tumor markers in CNS germ cell tumors.
Pediatr Blood Cancer
; 60(10): 1647-50, 2013 Oct.
Article
in English
| MEDLINE | ID: mdl-23788492
15.
Clinical, Pathological, and Molecular Characteristics of Diffuse Spinal Cord Gliomas.
J Neuropathol Exp Neurol
; 81(11): 865-872, 2022 10 18.
Article
in English
| MEDLINE | ID: mdl-35997552
16.
A phase II study of metronomic oral topotecan for recurrent childhood brain tumors.
Pediatr Blood Cancer
; 56(1): 39-44, 2011 Jan.
Article
in English
| MEDLINE | ID: mdl-21108437
17.
NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.
J Clin Oncol
; 39(7): 797-806, 2021 03 01.
Article
in English
| MEDLINE | ID: mdl-33507822
18.
Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or Meningioma.
Mol Cancer Ther
; 20(9): 1584-1591, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34224367
19.
Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.
Nat Med
; 27(1): 165-173, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33442015
20.
Diffuse midline glioma with novel, potentially targetable, FGFR2-VPS35 fusion.
Cold Spring Harb Mol Case Stud
; 6(5)2020 10.
Article
in English
| MEDLINE | ID: mdl-32839179